Blood Advances
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 7.7 | Q1 | 88.3% | 3.110 | Q1 | 97.8% |
| 2024 | 7.1 | Q1 | 87.9% | 2.901 | Q1 | 97.5% |
| 2023 | 7.4 | Q1 | 90.6% | 3.065 | Q1 | 97.9% |
| 2022 | 7.5 | Q1 | 92.2% | 3.070 | Q1 | 98.1% |
| 2021 | 7.6 | Q1 | 86.3% | 2.795 | Q1 | 97.8% |
| 2020 | — | — | 2.685 | Q1 | 97.4% | |
| 2019 | — | — | 2.226 | Q1 | 96.4% | |
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2473-9537
ISSN
2473-9529
region
Northern America
coverage
2016-2026